Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344307 (
analgesia
)
28,200
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A selective and sensitive method for the determination of piritramide in human plasma is described. A 1-ml aliquot of plasma was extracted with 10 ml of hexane-isoamyl alcohol (99.5:0.5, v/v) (extraction efficiency 86%) after addition of 50 microliters of 2 M ammonia and 20 microliters of aqueous strychnine solution (100 ng per 10 microliters) as internal standard. Gas chromatography was performed with J&W DB-1, 30 m x 0.53 mm I.D. separation column, film thickness 1.5 microns, using an nitrogen-
phosphorus
-sensitive detector. The assay was linear in the concentration range 3.75-2250 ng/ml (r = 0.999), with a lower limit of detection of 1-2 ng/ml. The precision was determined using spiked plasma samples (10 and 50 ng/ml), with coefficients of variation of 3.5 and 3.1% (intra-day; n = 5) and 4.6 and 4.1% (inter-day; n = 4). In the range 3.75-150 ng/ml, the accuracy of the assay was 3.36%. The method was used for the determination of piritramide plasma concentrations in patients receiving intra- or post-operative
analgesia
.
...
PMID:Sensitive determination of piritramide in human plasma by gas chromatography. 181 Sep 54
Osseous deposits secondary to advanced carcinoma of the prostate are a common feature of the disease. These deposits are most often seen in the lumbar spine and pelvis and cause severe and intractable pain, often requiring large quantities of strong
analgesia
for alleviation of pain. Relief of pain can be achieved by external irradiation of these deposits, but this relief may not be permanent and the disease may be so widespread that it is impracticable to treat all the deposits by irradiation. Deposits from carcinoma of the prostrate are usually multiple and all may cause pain at the same time. A method of delivering the radiation to all the deposits at the same time has been sought. Previous studies have shown that radioactive
phosphorus
(P32) can be used to obtain this localisation of radioactivity at sites of osseous activity. In this study 24 patients with bone metastases from carcinoma of the prostate were treated with radiophosphorus and methyl testosterone, or radiophosphorus with parathormone and calcium. An overall response rate of 58% shows this to be an effective palliative treatment. The results suggest there is a greater response when P32 is used in conjunction with parathormone and calcium, than with methyl testosterone.
...
PMID:Carcinoma of the prostate: the treatment of bone metastases by radiophosphorus. 730 44
Inorganic
phosphorus
and the associated potassium, magnesium, and sodium ion levels were measured in the serum and daily urine in the perioperative period in 210 patients of both sexes aged 31-84 years subjected to planned and urgent surgery on the abdominal organs. Control group consisted of 14 patients subjected to planned operations for inguinal hernias. Intraoperative hypophosphatemia was observed in all patients at the beginning, during, and immediately after the operation. The level of serum
phosphorus
decreased greater (48.1%) during operations performed under local anesthesia than under total anesthesia (by 24.5%) or under total anesthesia combined with epidural
analgesia
(by 20.4%). After the operation, changes in the serum
phosphorus
concentration directly depended on the severity of hemostatic disorders: after short operations, the level of serum
phosphorus
spontaneously normalized within the first 24 h after surgery. After more extensive interventions (resections of the stomach, large intestine, abdominoperineal operations), the decrease of serum
phosphorus
was 0.3 mmole/liter, on average, and persisted for at least 3-5 days after surgery. The changes were the greatest in patients subjected to urgent operations for ileus and peritonitis. In this group, manifest hypophosphatemia persisted for the entire period of observation, that is, for at least 5 days postoperation, and had to be corrected.
...
PMID:[Dynamics of indicators of blood inorganic phosphorus during gastrointestinal surgery]. 969 36
Currently, from the viewpoint of animal welfare, anesthesia or
analgesia
is required during experimental procedures in animals that are likely to cause pain. A part of these anesthetics have been reported to influence a blood biochemical level. It is important for us to understand the effect of the anesthetic on blood biochemistry when we choose the anesthetic agent to be used in experiments. In this study, we examined the blood biochemical changes in mice after administration of a new mixture of three anesthetic agents -medetomidine / midazolam / butorphanol (MMB). We subcutaneously administered two dose combinations of MMB (0.45 / 6 / 7.5 and 0.9 / 12 / 15 mg/kg) in mice, followed by administration of atipamezole, for reversal of anesthetic effects, after 1 hr. Thereafter, blood biochemistry was assessed at 1, 4 and 24 hr after MMB administration. We observed that MMB administration caused a transient increase in blood sugar, inorganic
phosphorus
, potassium and creatine kinase levels. These, however, returned to the reference range 24 hr after MMB administration. In conclusion, MMB changes the levels of some blood biochemical parameters, but not to an extent that would threaten health. However, when using laboratory animals, this effect of MMB may influence the experimental results, depending on the experimental content. Hence, the choice of anesthetic agents used in laboratory animals should be based on detailed knowledge of their pharmacological effects.
...
PMID:Blood biochemical changes in mice after administration of a mixture of three anesthetic agents. 2690 44